1/73
Looks like no tags are added yet.
Principles of antimicrobial therapy
goal is to administer a drug that destroys infectious agent and does not harm the host, a perfect drug does not exist
Selective toxicity(Stox)
central concept in antibiotic treatment, antibiotic drugs should selectively kill or inhibit pathogens, best drugs affect pathogens and not vertebrate cells
Selective toxicity and relationships
drugs can have good Stox, such as penicillins since they block cell walls which are only in bacteria; drugs can have bad Stox where they have toxicity to human cells because they act upon structures common to infective agent and host cells; as microbe becomes more similar to host, Stox becomes harder
Chemistry of antibiotics
new drugs created by chemically altering structure of naturally occurring antibiotics to create semisynthetic drugs
Synthetic drugs
laboratory-created drugs with unique actions
Broad spectrum antibiotics
effective against more than one group; problem is that it acts on normal flora and fauna; example is tetracyclines
Narrow spectrum antibiotics
targets specific group of bacteria; example is polymyxin
Bacteriostatics
cell growth of bacteria is prevented
Bactericidal
kills the bacteria
Types of administration
oral, injection, topical, intravenous(IV)
Oral administration
must pass through stomach and upper intestines; low pH and enzymes
Injection Administration
muscle, under skin
Topical administration
skin and eye infections
Discovery of antibiotics
in 1928 Dr. Alexander Fleming returned to a messy lab after vacation, Staphylococcus aureus stock plates were contaminated with a the mold Penicillium notatum, the mold prevented normal bacterial growth
Mechanisms of drug action
metabolic targets of chemotherapeutic agents; inhibition of cell wall synthesis, folic acid synthesis, nucleic acid(DNA&RNA) structure and function, cell membrane structure and function, and protein synthesis
Drugs targeting the cell wall
Penicillins, Cephalosporins, Carbapenems, Glycopeptides
Penicillins
blocks cross-linking of peptidoglycan, can be natural or synthetic; composed of thiazolidine ring, beta-lactam ring, and variable side chain
Natural penicillins
drug of choice for G+ cocci and some G- bacteria, are easily defeated by penicillinases
Penicillinases(beta-lactamases)
cleave the beta-lactam ring which are central to many drugs targeting the bacterial cell wall, clavulanic acid inhibits beta-lactamases(can be added to antibiotics)
Clavulanic acid
added to some drugs; Augmentin = amoxicillin + clavulanic acid
Semisynthetic penicillins
have modified side chains; include ampicillin, carbenicillin, amoxicillin(broader spectrum, do not resist penicillinase); some newer ones resist penicillinase(methicillin, nafcillin)
Cephalosporins
have a beta-lactam ring that can be chemically altered, some affected by beta-lactamases, similar mode of action to penicillins; composed of main ring, beta-lactam ring, and 2 variable R groups
Benefits of cephalosporins
fewer allergic reactions than penicillins
Carbapenems
beta-lactam ring, some can be used in cases of penicillin allergies, antibiotic of last resort due to serious side effects
Use of carbapenems
treatment of infections known or suspected to be caused by MDR bacteria
Glycopeptides
no beta-lactam ring, inhibits cell wall synthesis, a series of amino acids or peptide chain, must be given intravenously, most are natural
Types of glycopeptides
some are semi-synthetics being developed, fully synthetics seen as future direction; example is vancomycin which is an antibiotic of last resort
Drugs targeting folic acid synthesis
sulfonamides or sulfa drugs; first modern antibiotic drugs, synthetic
How Sulfa drugs work
tetrahydrofolic acid is a bacterial micronutrient that is made by cleavage of PABA(substrate), PABA cleaved by enzyme DHPS→sulfa drug inhibits that enzyme(no enzyme→no folic acid→no bacteria)
Competitive inhibition
a form of enzyme inhibition where binding of an inhibitor to the active site on the enzyme prevents binding of the substrate
Sulfa drug and competitive inhibition
sulfa drug=inhibitor; inhibitor binds to DHPS enzyme causing no enzyme-substrate(DHPS-PABA) interaction leading to no production of folic acid
Drugs targeting DNA or RNA
Quinolones and Rifampin(Rifampicin)
Quinolones
high potency/broad spectrum, targets DNA replication, readily absorbed from intestines, side effects are seizures
Types of quinolones
ciprofloxacin(anthrax, readily absorbed by intestines) and xifaxan(traveler’s diarrhea, not readily absorbed by intestines because its needed to stay in the gut to target the diarrhea-causing bacteria)
Rifampin(Rifampicin)
targets RNA polymerase(inhibits transcription), turns body fluids orange-red, used in drug cocktail(for TB and leprosy) to avoid resistance
Drugs targeting cell membranes
bind to LPS and disrupt membranes, antibiotics of last resort; polypeptide drugs and lipopeptide(daptomycin)
Polypeptide drugs
polymyxin, causes nephrotoxicity and neurotoxicity
Antibiotic drugs targeting protein synthesis
blocks translation by reacting with ribosome-MRNA complex, prokaryotic. and eukaryotic ribosomes are very different(Stox); aminoglycosides, tetracyclines, glycylcyclines, chloramphenicol, and erythromycin
Aminoglycosides
distorts ribosomes→translation errors, broad spectrum
Tetracyclines
blocks protein assembly, broad spectrum; side effects are GI disruption and hard tissue deposition(children/in utero)
Glycylcyclines
blocks protein assembly, newer semisynthetic derivatives of tetracyclines, good for tetracycline-resistance
Chloramphenicol
blocks protein assembly, antibiotic of last resort as it causes aplastic anemia(damaged blood stem cells)
Erythromycin
blocks protein assembly, broad spectrum, low toxicity
Antifungals
fungal cells are eukaryotic→special problems; most antibacterials are ineffective for fungi(Stox); target cell wall, plasma membranes, and microtubules
Antifungals that target cell wall
fungal cell walls contain beta-glucan which stabalizes the cell wall; echinocandin drugs target beta-glucan, called “penicillin of antifungals” as it is analagous to beta-lactams in targeting cell wall synthesis
Antifungals targeting plasma membranes
animal cholesterol maintains membrane structural integrity and fluidity, fungi also contain ergostal; polyenes and azoles
Polyenes
bind ergosterol, inserts and disrupts lipid structure causing ion leakage, derived from bacteria; Amphotericin B which treats serious systemic infections
Azoles
inhibit egosterol synthesis, treats systemic and topical mycoses; Imidazoles which treat superficial infections
Antifungals that inhibit microtubules
no cell division; griseofulvin
Griseofulvan
oral, systemic and topical mycoses(ringworm)
Anti-protozoans
most target intracellular components; anti-malarials(quinine and artemisinin), nitrazoxanide, metronidazole
Anti-protozoan problems
Selective toxicity; complex life cycles, each with unique metabolic pathways and structures
Anti-malarials
quinine and artemisinin; over the past 50 years falciparum malaria has become resistant to 5 other drug classes, one remains→artemisinin
Quinine
tree bark, used since 1600s, wide-spread resistance
Artemisinin
sweet wormwood, potent and effective especially in drug combinations, some resistance reported
Nitazoxanide
blocks respiration, kills intestinal amoeba(Giardia, Cryptosporidium)
Metronidazole
damages DNA(Giardia)
Anti-helminthics
biggest problem with selective toxicity; mebendzole and albenzadole, praziquantel, ivermectin
Mebendazole and albendazole
treats nematode infections, blocks transport of materials into cells
Praziquantel
treats trematodes and tapeworms, targets membranes(action unknown)
Ivermectin
treats nematodes including heartworm, interferes with parasites nervous system and muscle function
Anti-virals
human cell is responsible for host and virus well-being, selective toxicity is also hard; oseltamivir, acyclovir, ribavirin, remdesivir
Anti-viral major modes of action
block penetration, block transcription and translation of viral molecules, and prevent maturation
Oseltamivir
inhibits influenza A and B replication
Acyclovir
disrupts herpes DNA polymerase
Ribavirin
blocks RNA synthesis of respiratory infections
Remedesivir
polymerase inhibitor of SARS-CoV-2
Interferon(IFN)
benefits are decreased time of healing and complications of certain infections, decreased cold and papillomavirus symptoms, treats hepatitis C and genital warts(HIV)
Serious side effects
Drug Resistance
Adaptation of microbes to tolerate increasing amounts of antibiotics, due to genetic versatility and adaptability of microbial populations
Types of resistance
Intrinsic(spontaneous mutation) and acquired(acquisition of new gene, HGT)
How humans are making it worse
human overuse, global travel and globalization, vet over prescription, and the hospital factor
Human drug overuse
over prescription, addition of antibiotic to household products, improper use
Vet over prescription
80% of all antibiotics given to livestock
The hospital factor in drug resistance
environment continually exposes pathogens to a variety of antibiotics; house susceptible patients(weakened defenses), workforce may not strictly adhere to universal precautions